Vivesto Stock

Vivesto Intangible Assets

The Intangible Assets of Vivesto (VIVE.ST) as of Aug 10, 2026 is 140.10 M SEK. In the previous year, Intangible Assets was 192.29 M SEK — a change of -27.14% (lower).

Intangible Assets

140.10 MSEK

YoY

-27.14%

Last updated:

Intangible Assets of Vivesto is 2026 140.10 M SEK. Intangible Assets of Vivesto was 2025 192.29 M SEK. It decreases by -27.14% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Intangible Assets of Vivesto is 140.10 M SEK in 2026.

Intangible Assets of Vivesto changed from 192.29 M SEK to 140.10 M SEK, representing a -27.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Vivesto since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Vivesto historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vivesto

All Key Metrics — Vivesto